PFE Jan 2025 22.500 call
OPR - OPR Delayed Price. Currency in USD
Add to watchlist
As of 10:51AM EDT. Market open.
| Previous Close | 6.25 |
| Open | 6.08 |
| Bid | 5.05 |
| Ask | 7.15 |
| Strike | 22.50 |
| Expire Date | 2025-01-17 |
| Day's Range | 6.08 - 6.15 |
| Contract Range | N/A |
| Volume | |
| Open Interest | 3.74k |
Yahoo FinanceNovavax stock doubles after Sanofi deal marks 'new chapter' for company
Novavax stock popped Friday on news of a licensing deal and minority stake from Big Pharma player Sanofi.
ZacksPharma Stock Roundup: PFE DMD Study Patient Death, FDA Panel Meet for LLY's Donanemab
Pfizer (PFE) reports the death of a participant in a mid-stage study of its Duchenne drug. An FDA panel meeting to discuss Eli Lilly's (LLY) donanemab is set to take place on Jun 10.
GuruFocus.comDecoding Pfizer Inc (PFE): A Strategic SWOT Insight
Insightful Analysis of Pfizer Inc's Financial Health and Strategic Position
© 2024 Yahoo. All rights reserved.